Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01.
Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01.
复制标题
DOI:
10.1093/toxsci/kfab084
复制
发表时间:
2021-08-30
期刊:
影响因子:
--
通讯作者:
Naisbitt DJ
中科院分区:
文献类型:
--
作者:
Ogese MO;Lister A;Gardner J;Meng X;Alfirevic A;Pirmohamed M;Park BK;Naisbitt DJ
Drug rash with eosinophilia with systemic symptoms (DRESS) is a serious adverse event associated with use of the glycopeptide antibiotic vancomycin. Vancomycin-induced drug rash with eosinophilia with systemic symptoms is associated with the expression of human leukocyte antigen (HLA)-A*32:01, suggesting that the drug interacts with this HLA to activate CD8+ T cells. The purpose of this study was to utilize peripheral blood mononuclear cell from healthy donors to: (1) investigate whether expression of HLA-A*32:01 is critical for the priming naïve of T cells with vancomycin and (2) generate T-cell clones (TCC) to determine whether vancomycin exclusively activates CD8+ T cells and to define cellular phenotype, pathways of drug presentation and cross-reactivity. Dendritic cells were cultured with naïve T cells and vancomycin for 2 weeks. On day 14, cells were restimulated with vancomycin and T-cell proliferation was assessed by [3H]-thymidine incorporation. Vancomycin-specific TCC were generated by serial dilution and repetitive mitogen stimulation. Naïve T cells from HLA-A*02:01 positive and negative donors were activated with vancomycin; however the strength of the induced response was significantly stronger in donors expressing HLA-A*32:01. Vancomycin-responsive CD4+ and CD8+ TCC from HLA-A*32:01+ donors expressed high levels of CXCR3 and CCR4, and secreted IFN‐γ, IL-13, and cytolytic molecules. Activation of CD8+ TCC was HLA class I-restricted and dependent on a direct vancomycin HLA binding interaction with no requirement for processing. Several TCC displayed cross-reactivity with teicoplanin and daptomycin. To conclude, this study provides evidence that vancomycin primes naïve T cells from healthy donors expressing HLA-A*32:01 through a direct pharmacological binding interaction. Cross-reactivity of CD8+ TCC with teicoplanin provides an explanation for the teicoplanin reactions observed in vancomycin hypersensitive patients.
登录
查看更多内容
DOI:
10.1097/qad.0b013e328355fe8f
发表时间:
2012-07-17
期刊:
AIDS (London, England)
影响因子:
--
作者:
Norcross MA;Luo S;Lu L;Boyne MT;Gomarteli M;Rennels AD;Woodcock J;Margulies DH;McMurtrey C;Vernon S;Hildebrand WH;Buchli R
通讯作者:
Buchli R
影响因子:
158.5
作者:
Mallal, Simon;Phillips, Elizabeth;Benbow, Alastair
通讯作者:
Benbow, Alastair
影响因子:
15.9
作者:
Zanni, MP;von Greyerz, S;Pichler, WJ
通讯作者:
Pichler, WJ
影响因子:
3.7
作者:
Groom JR;Luster AD
通讯作者:
Luster AD
影响因子:
5.3
作者:
Blaskovich MAT;Hansford KA;Butler MS;Jia Z;Mark AE;Cooper MA
通讯作者:
Cooper MA